This study evaluated the presence of DNA hypermethylation at promoter regions of BRCA1 and RAD51C genes in peripheral blood lymphocytes from women affected by BC and/or OC who tested negative at the BRCA analysis, although they were at high risk to harbor pathogenic variants. The gene discussed is RAD51C; the disease is breast cancer.